Level Four Advisory Services LLC Reduces Holdings in Colgate-Palmolive Company $CL

Level Four Advisory Services LLC lowered its position in Colgate-Palmolive Company (NYSE:CL) by 16.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,013 shares of the company’s stock after selling 766 shares during the quarter. Level Four Advisory Services LLC’s holdings in Colgate-Palmolive were worth $365,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Brighton Jones LLC grew its stake in Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Colgate-Palmolive during the 1st quarter valued at approximately $606,000. Scotia Capital Inc. grew its position in shares of Colgate-Palmolive by 0.4% during the first quarter. Scotia Capital Inc. now owns 63,982 shares of the company’s stock worth $5,995,000 after buying an additional 249 shares in the last quarter. Avalon Trust Co increased its stake in shares of Colgate-Palmolive by 25.7% in the first quarter. Avalon Trust Co now owns 880 shares of the company’s stock worth $82,000 after buying an additional 180 shares during the last quarter. Finally, Commonwealth Equity Services LLC raised its holdings in Colgate-Palmolive by 2.2% in the first quarter. Commonwealth Equity Services LLC now owns 261,739 shares of the company’s stock valued at $24,525,000 after acquiring an additional 5,705 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.5%

Shares of NYSE CL opened at $79.96 on Tuesday. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a market cap of $64.45 billion, a price-to-earnings ratio of 22.46, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock’s 50 day simple moving average is $78.58 and its 200 day simple moving average is $84.37.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period last year, the company earned $0.91 earnings per share. Equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 17th were given a $0.52 dividend. The ex-dividend date was Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.26%.

Analyst Upgrades and Downgrades

CL has been the subject of several recent analyst reports. Barclays decreased their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Morgan Stanley decreased their price target on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research note on Monday, November 3rd. Raymond James Financial lowered their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a report on Monday, October 20th. UBS Group reduced their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 price target on Colgate-Palmolive in a report on Friday, October 10th. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.87.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.